BHWM
NBRV

Bay Harbor Wealth Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bay Harbor Wealth Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80
Closed – – 1354
2026
Q1 		$0 Hold
80
– – ﹤0.01% 1353
2025
Q4 		$0 Hold
80
– – ﹤0.01% 1353
2025
Q3 		$0 Hold
80
– – ﹤0.01% 1326
2025
Q2 		$0 Hold
80
– – ﹤0.01% 1315
2025
Q1 		$0 Buy
+80
New – ﹤0.01% 1161
2024
Q4 		– Sell
-80
Closed – – 194
2024
Q3 		$0 Hold
80
– – ﹤0.01% 181
2024
Q2 		$0 Buy
+80
New – ﹤0.01% 183
2024
Q1 		– Sell
-80
Closed – – 185
2023
Q4 		$0 Buy
+80
New – ﹤0.01% 182

Bay Harbor Wealth Management's NBRV Position: Q2 2026 in Review

Bay Harbor Wealth Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q2 2026, closing a stake of 80 shares.

Bay Harbor Wealth Management first reported a position in NBRV in Q4 2023 and held it in 8 quarters. The position peaked at $0 in Q1 2026. 0 funds tracked by Wall St. Rank hold NBRV as of Q2 2026.

  • Bay Harbor Wealth Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q2 2026 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 80 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q2 2026.
  • Bay Harbor Wealth Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2023 and held it in 8 quarters.
  • Bay Harbor Wealth Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $0 in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.